A drug can make children with the most common form of dwarfism taller – but height isn’t the same as a better life
pixelaway/Shutterstock A drug that helps children with the most common form of dwarfism grow taller has sparked an ethical debate within the dwarfism community. Some parents hope that as well as increasing size, it will prevent serious health complications and improve their children’s independence. But critics worry that a treatment focused on increasing height sends the message that dwarfism is something that needs to be corrected. The drug, vosoritide, sold as Voxzogo, is used to treat…
Read it at The Conversation See this on the map
What might happen next? AI-generated
These scenarios are written by an AI language model from the headline and summary above. They are not predictions from the newsroom, and they are not evidence of anything. Every one is given a deadline and checked against later coverage, and the score is published on the ledger — including the ones that miss.
ForecastGeo shows the headline and summary published by the newsroom and places the story on a map. The full article lives at the source.